- Home
- Publications
- Publication Search
- Publication Details
Title
TMC207 becomes bedaquiline, a new anti-TB drug
Authors
Keywords
-
Journal
Future Microbiology
Volume 8, Issue 9, Pages 1071-1080
Publisher
Future Medicine Ltd
Online
2013-09-11
DOI
10.2217/fmb.13.85
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis
- (2013) Andreas H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroCombination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosis
- (2012) Benoit Lechartier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase II Dose-Ranging Trial of the Early Bactericidal Activity of PA-824
- (2012) Andreas H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
- (2012) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure
- (2012) Elena Segala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Totally Drug-Resistant and Extremely Drug-Resistant Tuberculosis: The Same Disease?
- (2012) G. B. Migliori et al. CLINICAL INFECTIOUS DISEASES
- Tuberculosis: The drug development pipeline at a glance
- (2012) Baptiste Villemagne et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- New drugs for the treatment of tuberculosis: hope and reality [State of the Art Series. New tools. Number 2 in the series]
- (2012) J. H. Grosset et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Is repositioning of drugs a viable alternative in the treatment of tuberculosis?
- (2012) J. C. Palomino et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
- (2012) S. E. Dorman et al. JOURNAL OF INFECTIOUS DISEASES
- 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial
- (2012) Andreas H Diacon et al. LANCET
- Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
- (2012) Maria Tarcela Gler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Totally Drug-Resistant Tuberculosis in India
- (2011) Z. F. Udwadia et al. CLINICAL INFECTIOUS DISEASES
- Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients
- (2011) A. H. Diacon et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers
- (2011) Kelly E. Dooley et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
- (2011) P. E. Almeida Da Silva et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activities of TMC207, Rifampin, and Pyrazinamide againstMycobacterium tuberculosisInfection in Guinea Pigs
- (2010) Shaobin Shang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients
- (2010) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Interactions between New Antitubercular Drug Candidates SQ109 and TMC207
- (2010) V. M. Reddy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor
- (2009) E. Huitric et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- R207910 (TMC207) : un nouvel antibiotique pour le traitement de la tuberculose
- (2009) N. Lounis et al. MEDECINE ET MALADIES INFECTIEUSES
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared with That towards the Eukaryotic Homologue
- (2008) A. C. Haagsma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model
- (2008) N. Lounis et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started